Kristian Reich
Gründer bei MOONLAKE IMMUNOTHERAPEUTICS
Vermögen: 134 Mio $ am 30.04.2024
Aktive Positionen von Kristian Reich
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 05.04.2022 | - |
Gründer | 05.04.2022 | - | |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2021 | - |
Gründer | 01.05.2021 | - | |
JeruCON Beratungsgesellschaft mbH | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Gründer | - | - | |
derma2go AG
derma2go AG Internet Software/ServicesTechnology Services Derma2go AG operates an online platform for dermatological consultation. The company is based in Zurich, Switzerland. The Swiss company was founded in 2018 by Christian Greis and Vahid Djamei. Christian Greis has been the CEO since 2018. | Direktor/Vorstandsmitglied | - | - |
Dermagnostix GmbH | Direktor/Vorstandsmitglied | - | - |
Proderma Foundation | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Kristian Reich
Ehemalige bekannte Positionen von Kristian Reich
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Dermatologikum Hamburg GmbH
Dermatologikum Hamburg GmbH Medical/Nursing ServicesHealth Services Dermatologikum Hamburg GmbH operates dermatologist clinics. Its services include prevention and skin checks, phototherapy, general dermatology, acne and rosacea, hair and scalp disorders, skin cancer and dermatological oncology, psoriasis, neurodermatitis and vascular & venous disease treatment. The company was founded by Volker Steinkraus in September 1997 and is headquartered in Hamburg, Germany. | Corporate Officer/Principal | 01.01.2005 | 01.01.2015 |
University of Gottingen | Corporate Officer/Principal | 01.01.1996 | - |
Ausbildung von Kristian Reich
University of Freiburg | Undergraduate Degree |
Technische Universität München | Doctorate Degree |
University of Gottingen | Doctorate Degree |
Statistik
International
Deutschland | 8 |
Schweiz | 4 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Founder | 3 |
Doctorate Degree | 3 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
Private Unternehmen | 6 |
---|---|
Dermatologikum Hamburg GmbH
Dermatologikum Hamburg GmbH Medical/Nursing ServicesHealth Services Dermatologikum Hamburg GmbH operates dermatologist clinics. Its services include prevention and skin checks, phototherapy, general dermatology, acne and rosacea, hair and scalp disorders, skin cancer and dermatological oncology, psoriasis, neurodermatitis and vascular & venous disease treatment. The company was founded by Volker Steinkraus in September 1997 and is headquartered in Hamburg, Germany. | Health Services |
derma2go AG
derma2go AG Internet Software/ServicesTechnology Services Derma2go AG operates an online platform for dermatological consultation. The company is based in Zurich, Switzerland. The Swiss company was founded in 2018 by Christian Greis and Vahid Djamei. Christian Greis has been the CEO since 2018. | Technology Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
JeruCON Beratungsgesellschaft mbH | |
Dermagnostix GmbH | |
Proderma Foundation |
- Börse
- Insiders
- Kristian Reich
- Erfahrung